Biotts SA

About:

Biotts develop proprietary drug delivery technologies and drug formulas in the field of diabetology.

Top Investors: Google for Startups, Montis Capital Group

Description:

Biotts is a biotech company specializing in Transdermal Drug Delivery. Biotts develops its own transdermal drug products and make their expertise and technology available to the pharmaceutical industry through technical development collaborations.

Total Funding Amount:

$1.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Bielany Wroclawskie, Dolnoslaskie, Poland

Founded Date:

2018-07-01

Contact Email:

office(AT)biotts.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2021-10-05

IPO Status:

Private

Industries: